You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0071 Characterization of NNC141-0100, a therapeutic antibody targeting inhibitory CD94/NKG2A receptors expressed in inflamed joints of rheumatoid arthritis patients

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Innate immunity in rheumatic diseases
AB0071 Characterization of NNC141-0100, a therapeutic antibody targeting inhibitory CD94/NKG2A receptors expressed in inflamed joints of rheumatoid arthritis patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Pascal V, Sundström Y, Fasth A, et al
AB0071 Characterization of NNC141-0100, a therapeutic antibody targeting inhibitory CD94/NKG2A receptors expressed in inflamed joints of rheumatoid arthritis patients
Annals of the Rheumatic Diseases 2013;71:641.